Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FPAQM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injectors. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. This IDC authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and medical supplies to Department of Defense healthcare sites. The company's portfolio includes an extensive array of pharmaceutical products ranging from branded and generic prescription medications to biologics and medical consumables across multiple delivery formats including injections, tablets, and auto-injectors. The award of this Nucala auto-injector delivery order reflects the contractor's continued role in fulfilling specialized pharmaceutical requirements for military healthcare operations, with performance occurring at the company's Park Ridge, Illinois facility.
Quick answers
Who was awarded contract SPE2DB25FPAQM?
SPE2DB25FPAQM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FPAQM worth?
The government has obligated $5,679 on SPE2DB25FPAQM.
Is contract SPE2DB25FPAQM an order under another contract?
Yes. SPE2DB25FPAQM is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQM competed?
The extent of competition for SPE2DB25FPAQM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award